PRICE T ROWE ASSOCIATES INC /MD/ - 10X GENOMICS INC ownership

10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 250 filers reported holding 10X GENOMICS INC in Q2 2022. The put-call ratio across all filers is 0.59 and the average weighting 1.0%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of 10X GENOMICS INC
ValueSharesWeighting
Q3 2023$110,859
-25.3%
2,687,451
+1.1%
0.02%
-23.8%
Q2 2023$148,386
+10.2%
2,657,324
+10.1%
0.02%
+5.0%
Q1 2023$134,676
+83.7%
2,413,960
+20.0%
0.02%
+66.7%
Q4 2022$73,323
-99.9%
2,012,175
-14.3%
0.01%
+9.1%
Q3 2022$66,907,000
+10.5%
2,349,229
+75.5%
0.01%
+37.5%
Q2 2022$60,571,000
-30.8%
1,338,586
+16.3%
0.01%
-11.1%
Q1 2022$87,538,000
-45.4%
1,150,753
+6.8%
0.01%
-35.7%
Q4 2021$160,461,000
+13.4%
1,077,212
+10.8%
0.01%
+7.7%
Q3 2021$141,506,000
-32.1%
972,017
-8.7%
0.01%
-31.6%
Q2 2021$208,477,000
+38.6%
1,064,638
+28.1%
0.02%
+26.7%
Q1 2021$150,430,000
+24.1%
831,103
-2.9%
0.02%
+25.0%
Q4 2020$121,250,000
+43.2%
856,286
+26.1%
0.01%
+20.0%
Q3 2020$84,672,000
+143.4%
679,114
+74.4%
0.01%
+150.0%
Q2 2020$34,787,000
+61.8%
389,510
+12.9%
0.00%
+33.3%
Q1 2020$21,494,000
+53.1%
344,894
+87.4%
0.00%
+50.0%
Q4 2019$14,036,000
-59.1%
184,084
-73.0%
0.00%
-60.0%
Q3 2019$34,343,000681,4000.01%
Other shareholders
10X GENOMICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Venrock Management VI, LLC 962,309$188,439,00095.08%
Foresite Capital Management II, LLC 1,753,528$343,376,00092.37%
Foresite Capital Management I, LLC 750,000$146,865,00088.53%
12 West Capital Management LP 1,922,000$376,366,00015.78%
Financial Consulate Inc. 141,258$27,661,0009.97%
FINANCIAL CONSULATE, INC 141,258$27,661,0009.97%
Meritech Capital Associates V L.L.C. 1,793,871$351,276,0007.51%
Andar Capital Management HK Ltd 51,000$9,987,0006.81%
JS Capital Management LLC 540,589$105,858,0005.12%
Renaissance Capital LLC 97,281$19,050,0003.01%
View complete list of 10X GENOMICS INC shareholders